{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "13",
                "@timestamp": "2023-07-13T20:47:09.000009-04:00",
                "@year": "2023",
                "@month": "07"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2022",
                "@month": "06"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": [
                {"xocs:funding-agency-matched-string": "Daiichi"},
                {"xocs:funding-agency-matched-string": "Daiichi Sankyo and Sanofi"},
                {"xocs:funding-agency-matched-string": "Merck Biopharma"},
                {"xocs:funding-agency-matched-string": "Taiho"},
                {
                    "xocs:funding-agency-matched-string": "Amgen",
                    "xocs:funding-agency": "Amgen",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100002429",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "Bristol Myers Squibb",
                    "xocs:funding-agency-acronym": "BMS",
                    "xocs:funding-agency": "Bristol-Myers Squibb",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100002491",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "Eli Lilly",
                    "xocs:funding-agency": "Eli Lilly and Company",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100004312",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "AstraZeneca",
                    "xocs:funding-agency": "AstraZeneca",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100004325",
                    "xocs:funding-agency-country": "http://sws.geonames.org/2635167/"
                },
                {
                    "xocs:funding-agency-matched-string": "Bayer",
                    "xocs:funding-agency": "Bayer",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100004326",
                    "xocs:funding-agency-country": "http://sws.geonames.org/2921044/"
                },
                {
                    "xocs:funding-agency-matched-string": "Merck",
                    "xocs:funding-agency": "Merck",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100004334",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "Novartis",
                    "xocs:funding-agency": "Novartis",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100004336",
                    "xocs:funding-agency-country": "http://sws.geonames.org/2658434/"
                },
                {
                    "xocs:funding-agency-matched-string": "Roche",
                    "xocs:funding-agency": "Roche",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100004337",
                    "xocs:funding-agency-country": "http://sws.geonames.org/2658434/"
                },
                {
                    "xocs:funding-agency-matched-string": "Sanofi",
                    "xocs:funding-agency": "Sanofi",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100004339",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "Celgene",
                    "xocs:funding-agency": "Celgene",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100006436",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "Boehringer Ingelheim",
                    "xocs:funding-agency": "Boehringer Ingelheim",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100008349",
                    "xocs:funding-agency-country": "http://sws.geonames.org/2921044/"
                },
                {
                    "xocs:funding-agency-matched-string": "Takeda",
                    "xocs:funding-agency-acronym": "TPC",
                    "xocs:funding-agency": "Takeda Pharmaceutical Company",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100008373",
                    "xocs:funding-agency-country": "http://sws.geonames.org/1861060/"
                },
                {
                    "xocs:funding-agency-matched-string": "Merck KGaA",
                    "xocs:funding-agency": "Merck KGaA",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100009945",
                    "xocs:funding-agency-country": "http://sws.geonames.org/2921044/"
                },
                {
                    "xocs:funding-agency-matched-string": "Merck Sharp & Dohme",
                    "xocs:funding-agency-acronym": "MSD",
                    "xocs:funding-agency": "Merck Sharp and Dohme",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100009947",
                    "xocs:funding-agency-country": "http://sws.geonames.org/2635167/"
                },
                {
                    "xocs:funding-agency-matched-string": "Pierre Fabre",
                    "xocs:funding-agency": "Les Laboratories Pierre Fabre",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100013226",
                    "xocs:funding-agency-country": "http://sws.geonames.org/3017382/"
                },
                {
                    "xocs:funding-agency-matched-string": "Astellas",
                    "xocs:funding-agency": "Astellas Pharma",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100004948",
                    "xocs:funding-agency-country": "http://sws.geonames.org/1861060/"
                },
                {
                    "xocs:funding-agency-matched-string": "Servier",
                    "xocs:funding-agency": "Servier",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100011725",
                    "xocs:funding-agency-country": "http://sws.geonames.org/3017382/"
                },
                {
                    "xocs:funding-agency-matched-string": "Institut de Recherches Internationales Servier",
                    "xocs:funding-agency-acronym": "IRIS",
                    "xocs:funding-agency": "Institut de Recherches Servier",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100013945",
                    "xocs:funding-agency-country": "http://sws.geonames.org/3017382/"
                }
            ],
            "xocs:funding-addon-generated-timestamp": "2022-11-16T04:04:40.392Z",
            "xocs:funding-text": [
                {"$": "We thank Georgii Filatov and Richard Crampton of Springer Healthcare Communications, who wrote the outline and subsequent drafts of this manuscript. This medical writing assistance was funded by Servier ."},
                {"$": "We thank Georgii Filatov and Richard Crampton of Springer Healthcare Communications, who wrote the outline and subsequent drafts of this manuscript. This medical writing assistance was funded by Servier. This work was supported by Institut de Recherches Internationales Servier, France (no grant number). TY has received honoraria for speaking engagements from Taiho, Chugai, Eli Lilly, Sanofi, Takeda, Merck Biopharma and Bayer; and research expenses from Taiho, Sumitomo Dainippon, Ono, Chugai, Amgen, Parexel International, Merck Sharp & Dohme (MSD), Daiichi Sankyo and Sanofi. EVC has participated in advisory boards for Array, Astellas, AstraZeneca, Bayer, BeiGene, Biocartis, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Daiichi, Halozyme, GlaxoSmithKline, Incyte, Ipsen, Lilly, MSD, Merck KGaA, Novartis, Pierre Fabre, Roche, Servier, Sirtex and Taiho, and has received research grants (paid to his institution) from Amgen, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Ipsen, Lilly, MSD, Merck KGaA, Novartis, Roche and Servier. JL has received honoraria for speaking engagements from Henrui, Eli Lilly, Sanofi, Merck, Bayer and Taiho; and research funding from Taiho, Merck, MSD and Henrui. LS, VS and AO have received financial support for their research from Taiho via their respective institutions. LX, PA, RF, VC and NA are employees of Servier. All other authors have declared no conflicts of interest."}
            ],
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Japan",
                            "@afid": "60010925",
                            "@country": "jpn",
                            "city": "Kashiwa",
                            "organization": [
                                {"$": "Department of Gastroenterology and Gastrointestinal Oncology"},
                                {"$": "National Cancer Center Hospital East"}
                            ],
                            "affiliation-id": {
                                "@afid": "60010925",
                                "@dptid": "103589809"
                            },
                            "@affiliation-instance-id": "S2059702922001314-34b8e54f8fa73a8de887d00a72737c00",
                            "ce:source-text": "Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan",
                            "@dptid": "103589809"
                        },
                        "author": [
                            {
                                "preferred-name": {
                                    "ce:given-name": "T.",
                                    "ce:initials": "T.",
                                    "ce:surname": "Yoshino",
                                    "ce:indexed-name": "Yoshino T."
                                },
                                "@author-instance-id": "S2059702922001314-4d8ceb2b71d98f8fea9b390ad61b9803",
                                "@seq": "1",
                                "ce:initials": "T.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Yoshino",
                                "@auid": "57205400013",
                                "ce:indexed-name": "Yoshino T."
                            },
                            {
                                "preferred-name": {
                                    "ce:given-name": "A.",
                                    "ce:initials": "A.",
                                    "ce:surname": "Ohtsu",
                                    "ce:indexed-name": "Ohtsu A."
                                },
                                "@author-instance-id": "S2059702922001314-894bc7c198da422c17a2f657aad2ce21",
                                "@seq": "12",
                                "ce:initials": "A.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Ohtsu",
                                "@auid": "7005282688",
                                "ce:indexed-name": "Ohtsu A."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Belgium",
                            "@afid": "60031069",
                            "@country": "bel",
                            "city": "Leuven",
                            "organization": [
                                {"$": "Digestive Oncology"},
                                {"$": "University Hospitals Gasthuisberg and KU Leuven"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60031069",
                                    "@dptid": "107923404"
                                },
                                {"@afid": "60025063"}
                            ],
                            "@affiliation-instance-id": "S2059702922001314-477a696c5b80ad4d3226bb57e6126996",
                            "ce:source-text": "Digestive Oncology, University Hospitals Gasthuisberg and KU Leuven, Leuven, Belgium",
                            "@dptid": "107923404"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "E.",
                                "ce:initials": "E.",
                                "ce:surname": "Van Cutsem",
                                "ce:indexed-name": "Van Cutsem E."
                            },
                            "@author-instance-id": "S2059702922001314-7730c9a30f7601d3648e87bf2e445278",
                            "@seq": "2",
                            "ce:initials": "E.",
                            "@date-locked": "2023-04-13T00:30:11.242",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Van Cutsem",
                            "@auid": "7005959932",
                            "ce:indexed-name": "Van Cutsem E."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60121918",
                            "@country": "chn",
                            "city": "Shanghai",
                            "organization": [
                                {"$": "Department of Oncology"},
                                {"$": "Shanghai East Hospital Tongji University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60121918",
                                    "@dptid": "126737073"
                                },
                                {"@afid": "60073652"}
                            ],
                            "@affiliation-instance-id": "S2059702922001314-e66dcf34dea573971e1a10e1493168e3",
                            "ce:source-text": "Department of Oncology, Shanghai East Hospital Tongji University, Shanghai, China",
                            "@dptid": "126737073"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "J.",
                                "ce:initials": "J.",
                                "ce:surname": "Li",
                                "ce:indexed-name": "Li J."
                            },
                            "@author-instance-id": "S2059702922001314-98051faa660b475ed65b7cac5bc3db55",
                            "@seq": "3",
                            "ce:initials": "J.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Li",
                            "@auid": "57190345301",
                            "ce:indexed-name": "Li J."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60008510",
                            "@country": "chn",
                            "city": "Beijing",
                            "organization": [
                                {"$": "Department of Gastrointestinal Oncology"},
                                {"$": "Peking University Cancer Hospital and Institute"}
                            ],
                            "affiliation-id": {
                                "@afid": "60008510",
                                "@dptid": "109961116"
                            },
                            "@affiliation-instance-id": "S2059702922001314-59efc3c4092751cf2fa3f5fa2f9e11ac",
                            "ce:source-text": "Department of Gastrointestinal Oncology, Peking University Cancer Hospital and Institute, Beijing, China",
                            "@dptid": "109961116"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "L.",
                                "ce:initials": "L.",
                                "ce:surname": "Shen",
                                "ce:indexed-name": "Shen L."
                            },
                            "@author-instance-id": "S2059702922001314-27c56b6d2116018a8c2cb3cd2ba193a7",
                            "@seq": "4",
                            "ce:initials": "L.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Shen",
                            "@auid": "57250380300",
                            "ce:indexed-name": "Shen L."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "South Korea",
                            "@afid": "60068691",
                            "@country": "kor",
                            "city": "Seoul",
                            "organization": [
                                {"$": "Department of Oncology"},
                                {"$": "Asan Medical Center"}
                            ],
                            "affiliation-id": {
                                "@afid": "60068691",
                                "@dptid": "113759348"
                            },
                            "@affiliation-instance-id": "S2059702922001314-dc457ecd5188092a30dcf80d0e23c498",
                            "ce:source-text": "Department of Oncology, Asan Medical Center, Seoul, Republic of Korea",
                            "@dptid": "113759348"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "T. W.",
                                "ce:initials": "T.W.",
                                "ce:surname": "Kim",
                                "ce:indexed-name": "Kim T.W."
                            },
                            "@author-instance-id": "S2059702922001314-36c462ad8d3abacee983c34d643bc927",
                            "@seq": "5",
                            "ce:initials": "T.W.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Kim",
                            "@auid": "56504151300",
                            "ce:indexed-name": "Kim T.W."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60002620",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Division of Medical Oncology"},
                                {"$": "Department of Internal Medicine"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University and King Chulalongkorn Memorial Hospital"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60002620",
                                    "@dptid": "118220109"
                                },
                                {"@afid": "60022183"},
                                {"@afid": "60028190"}
                            ],
                            "@affiliation-instance-id": "S2059702922001314-77170a03cb8f3910107ee8ad12ff3ec2",
                            "ce:source-text": "Division of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand",
                            "@dptid": "118220109"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "V.",
                                "ce:initials": "V.",
                                "ce:surname": "Sriuranpong",
                                "ce:indexed-name": "Sriuranpong V."
                            },
                            "@author-instance-id": "S2059702922001314-3fd7ea25122fd1823caee6a7edba0af6",
                            "@seq": "6",
                            "ce:initials": "V.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Sriuranpong",
                            "@auid": "6603599644",
                            "ce:indexed-name": "Sriuranpong V."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "France",
                            "@afid": "60004412",
                            "@date-locked": "2023-07-03T08:50:30.125",
                            "@country": "fra",
                            "city": "Suresnes",
                            "organization": [
                                {"$": "R&D Department"},
                                {"$": "Institut de Recherches Internationales Servier"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60004412",
                                    "@dptid": "129853931"
                                },
                                {"@afid": "60017173"}
                            ],
                            "@affiliation-instance-id": "S2059702922001314-f6e09005db8d5daa930bf3e13156cd8b",
                            "ce:source-text": "R&D Department, Institut de Recherches Internationales Servier, Suresnes, France",
                            "@dptid": "129853931"
                        },
                        "author": [
                            {
                                "preferred-name": {
                                    "ce:given-name": "L.",
                                    "ce:initials": "L.",
                                    "ce:surname": "Xuereb",
                                    "ce:indexed-name": "Xuereb L."
                                },
                                "@author-instance-id": "S2059702922001314-03d4fe3496e515d12ffe2765788fc366",
                                "@seq": "7",
                                "ce:initials": "L.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Xuereb",
                                "@auid": "36626782800",
                                "ce:indexed-name": "Xuereb L."
                            },
                            {
                                "preferred-name": {
                                    "ce:given-name": "P.",
                                    "ce:initials": "P.",
                                    "ce:surname": "Aubel",
                                    "ce:indexed-name": "Aubel P."
                                },
                                "@author-instance-id": "S2059702922001314-336451b3b212abeb99e29cf3a49b3a72",
                                "@seq": "8",
                                "ce:initials": "P.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Aubel",
                                "@auid": "57218401600",
                                "ce:indexed-name": "Aubel P."
                            },
                            {
                                "preferred-name": {
                                    "ce:given-name": "R.",
                                    "ce:initials": "R.",
                                    "ce:surname": "Fougeray",
                                    "ce:indexed-name": "Fougeray R."
                                },
                                "@author-instance-id": "S2059702922001314-75e413e69ceb08e4c5901c30af235f14",
                                "@seq": "9",
                                "ce:initials": "R.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Fougeray",
                                "@auid": "57579080500",
                                "ce:indexed-name": "Fougeray R."
                            },
                            {
                                "preferred-name": {
                                    "ce:given-name": "V.",
                                    "ce:initials": "V.",
                                    "ce:surname": "Cattan",
                                    "ce:indexed-name": "Cattan V."
                                },
                                "@author-instance-id": "S2059702922001314-830118b1ce29e3ad7d2477f87954326d",
                                "@seq": "10",
                                "ce:initials": "V.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Cattan",
                                "@auid": "57212115567",
                                "ce:indexed-name": "Cattan V."
                            },
                            {
                                "preferred-name": {
                                    "ce:given-name": "N.",
                                    "ce:initials": "N.",
                                    "ce:surname": "Amellal",
                                    "ce:indexed-name": "Amellal N."
                                },
                                "@author-instance-id": "S2059702922001314-f3aebdb42de4c0354889ce3dbcd51ba4",
                                "@seq": "11",
                                "ce:initials": "N.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Amellal",
                                "@auid": "57214141930",
                                "ce:indexed-name": "Amellal N."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60014334",
                            "@country": "usa",
                            "city": "Boston",
                            "organization": [
                                {"$": "Department of Medical Oncology"},
                                {"$": "Dana Farber Cancer Institute"}
                            ],
                            "affiliation-id": {
                                "@afid": "60014334",
                                "@dptid": "113623573"
                            },
                            "@affiliation-instance-id": "S2059702922001314-fdb62c428614db1a0a12355f14de1056",
                            "ce:source-text": "Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA",
                            "@dptid": "113623573"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "R. J.",
                                "ce:initials": "R.J.",
                                "ce:surname": "Mayer",
                                "ce:indexed-name": "Mayer R.J."
                            },
                            "@author-instance-id": "S2059702922001314-040ef580f0ed25d3807048b8e836aeb3",
                            "@seq": "13",
                            "ce:initials": "R.J.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Mayer",
                            "@auid": "57203233795",
                            "ce:indexed-name": "Mayer R.J."
                        }]
                    }
                ],
                "citation-title": "Effect of KRAS codon 12 or 13 mutations on survival with trifluridine/tipiracil in pretreated metastatic colorectal cancer: a meta-analysis",
                "abstracts": "Â© 2022 The Author(s)Background: KRAS gene mutations can predict prognosis and treatment response in patients with metastatic colorectal cancer (mCRC). Methods: We undertook a meta-analysis of three randomized, placebo-controlled trials (RECOURSE, TERRA and J003) to investigate the impact of KRAS mutations in codons 12 or 13 on overall survival (OS) and progression-free survival in patients receiving trifluridine/tipiracil (FTD/TPI) for refractory mCRC. Results: A total of 1375 patients were included, of whom 478 had a KRAS codon 12 mutation and 130 had a KRAS codon 13 mutation. In univariate analyses, the absence of a KRAS codon 12 mutation was found to significantly increase the OS benefit of FTD/TPI relative to placebo compared with the presence of the mutation {hazard ratio (HR), 0.62 [95% confidence interval (CI): 0.53-0.72] versus 0.86 (0.70-1.05), respectively; interaction P = 0.0206}. Multivariate analyses showed that taking confounding factors into account reduced the difference in treatment effect between the presence and the absence of KRAS codon 12 mutations, confirming that treatment benefit was maintained in patients with [HR, 0.73 (95% CI: 0.59-0.89)] and without [HR, 0.63 (95% CI: 0.54-0.74)] codon 12 mutations (interaction P = 0.2939). KRAS mutations in codon 13 did not reduce the OS benefit of FTD/TPI relative to placebo, and, furthermore, KRAS mutations at either codon 12 or codon 13 did not affect the progression-free survival benefit. Conclusions: Treatment with FTD/TPI produced a survival benefit, relative to placebo, regardless of KRAS codon 12 or 13 mutation status in patients with previously treated mCRC.",
                "correspondence": {
                    "affiliation": {
                        "country": "Japan",
                        "address-part": "6-5-1, Kashiwanoha",
                        "postal-code": "277-8577",
                        "@country": "jpn",
                        "city": "Kashiwa",
                        "state": "Chiba"
                    },
                    "person": {
                        "ce:initials": "T.",
                        "ce:surname": "Yoshino",
                        "ce:indexed-name": "Yoshino T."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "KRAS",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "meta-analysis",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "metastatic colorectal cancer",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "survival",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "trifluridine/tipiracil",
                            "@xml:lang": "eng",
                            "@original": "y"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "https://www.journals.elsevier.com/esmo-open/",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {"@xml:lang": "eng"},
                    "volisspag": {"voliss": {
                        "@volume": "7",
                        "@issue": "3"
                    }},
                    "@type": "j",
                    "sourcetitle": "ESMO Open",
                    "publicationdate": {
                        "month": "06",
                        "year": "2022",
                        "date-text": "June 2022",
                        "day": "01"
                    },
                    "sourcetitle-abbrev": "ESMO Open",
                    "@country": "gbr",
                    "issn": {
                        "$": "20597029",
                        "@type": "electronic"
                    },
                    "publicationyear": {"@first": "2022"},
                    "publisher": {"publishername": "Elsevier B.V."},
                    "article-number": "100511",
                    "@srcid": "21100873339"
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "16",
                                    "classification-description": "Cancer"
                                },
                                {
                                    "classification-code": "22",
                                    "classification-description": "Human Genetics"
                                },
                                {
                                    "classification-code": "29",
                                    "classification-description": "Clinical and Experimental Biochemistry"
                                },
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                },
                                {
                                    "classification-code": "48",
                                    "classification-description": "Gastroenterology"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": [
                                {"$": "2730"},
                                {"$": "1306"}
                            ]
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": [
                                {"$": "MEDI"},
                                {"$": "BIOC"}
                            ]
                        }
                    ]},
                    "chemicalgroup": {"chemicals": [
                        {
                            "@source": "esbd",
                            "chemical": [
                                {
                                    "cas-registry-number": [
                                        {"$": "755037-03-7"},
                                        {"$": "1019206-88-2"}
                                    ],
                                    "chemical-name": "regorafenib"
                                },
                                {
                                    "cas-registry-number": "733030-01-8",
                                    "chemical-name": "tipiracil plus trifluridine"
                                },
                                {
                                    "cas-registry-number": "85306-28-1",
                                    "chemical-name": "protein p21"
                                },
                                {
                                    "cas-registry-number": "65-71-4",
                                    "chemical-name": "thymine"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "183204-74-2"},
                                        {"$": "183204-72-0"}
                                    ],
                                    "chemical-name": "tipiracil"
                                },
                                {
                                    "cas-registry-number": "70-00-8",
                                    "chemical-name": "trifluridine"
                                },
                                {
                                    "cas-registry-number": "66-22-8",
                                    "chemical-name": "uracil"
                                }
                            ]
                        },
                        {
                            "@source": "nlm",
                            "chemical": [
                                {"chemical-name": "Codon"},
                                {"chemical-name": "KRAS protein, human"},
                                {"chemical-name": "Proto-Oncogene Proteins p21(ras)"},
                                {"chemical-name": "Pyrrolidines"},
                                {"chemical-name": "Thymine"},
                                {"chemical-name": "tipiracil"},
                                {"chemical-name": "Trifluridine"},
                                {"chemical-name": "Uracil"}
                            ]
                        }
                    ]}
                },
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "We thank Georgii Filatov and Richard Crampton of Springer Healthcare Communications, who wrote the outline and subsequent drafts of this manuscript. This medical writing assistance was funded by Servier. This work was supported by Institut de Recherches Internationales Servier, France (no grant number). TY has received honoraria for speaking engagements from Taiho, Chugai, Eli Lilly, Sanofi, Takeda, Merck Biopharma and Bayer; and research expenses from Taiho, Sumitomo Dainippon, Ono, Chugai, Amgen, Parexel International, Merck Sharp & Dohme (MSD), Daiichi Sankyo and Sanofi. EVC has participated in advisory boards for Array, Astellas, AstraZeneca, Bayer, BeiGene, Biocartis, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Daiichi, Halozyme, GlaxoSmithKline, Incyte, Ipsen, Lilly, MSD, Merck KGaA, Novartis, Pierre Fabre, Roche, Servier, Sirtex and Taiho, and has received research grants (paid to his institution) from Amgen, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Ipsen, Lilly, MSD, Merck KGaA, Novartis, Roche and Servier. JL has received honoraria for speaking engagements from Henrui, Eli Lilly, Sanofi, Merck, Bayer and Taiho; and research funding from Taiho, Merck, MSD and Henrui. LS, VS and AO have received financial support for their research from Taiho via their respective institutions. LX, PA, RF, VC and NA are employees of Servier. All other authors have declared no conflicts of interest.",
                        "@xml:lang": "eng"
                    },
                    "grant": [
                        {
                            "grant-agency": {
                                "@iso-code": "fra",
                                "$": "Servier"
                            },
                            "grant-agency-id": "501100011725"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "fra",
                                "$": "Servier"
                            },
                            "grant-agency-id": "501100011725"
                        }
                    ]
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2022 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "external-source": "MEDLINE",
                "dbcollection": [
                    {"$": "EMBASE"},
                    {"$": "MEDL"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "31",
                    "@timestamp": "BST 13:27:49",
                    "@year": "2022",
                    "@month": "07"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2018681961",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "940778114",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20220532440",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "35688062",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "20221801478",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20222025933",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "85131739522",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85131739522",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "638221104",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "911675116",
                            "@idtype": "OSIN"
                        }
                    ],
                    "ce:pii": "S2059702922001314",
                    "ce:ern": "pii:S2059702922001314",
                    "ce:doi": "10.1016/j.esmoop.2022.100511"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "27",
                "reference": [
                    {
                        "ref-fulltext": "Yaeger, R., Cowell, E., Chou, J.F., et al. RAS mutations affect pattern of metastatic spread and increase propensity for brain metastasis in colorectal cancer. Cancer 121:8 (2015), 1195\u20131203.",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "RAS mutations affect pattern of metastatic spread and increase propensity for brain metastasis in colorectal cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib1",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84927014631",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "121",
                                    "@issue": "8"
                                },
                                "pagerange": {
                                    "@first": "1195",
                                    "@last": "1203"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Yaeger",
                                        "ce:indexed-name": "Yaeger R."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Cowell",
                                        "ce:indexed-name": "Cowell E."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.F.",
                                        "@_fa": "true",
                                        "ce:surname": "Chou",
                                        "ce:indexed-name": "Chou J.F."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer"
                        },
                        "ce:source-text": "Yaeger R, Cowell E, Chou JF, et al. RAS mutations affect pattern of metastatic spread and increase propensity for brain metastasis in colorectal cancer. Cancer. 2015;121(8):1195-1203."
                    },
                    {
                        "ref-fulltext": "Van Cutsem, E., Cervantes, A., Adam, R., et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol 27:8 (2016), 1386\u20131422.",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "ESMO consensus guidelines for the management of patients with metastatic colorectal cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib2",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84984985398",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "27",
                                    "@issue": "8"
                                },
                                "pagerange": {
                                    "@first": "1386",
                                    "@last": "1422"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Van Cutsem",
                                        "ce:indexed-name": "Van Cutsem E."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Cervantes",
                                        "ce:indexed-name": "Cervantes A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Adam",
                                        "ce:indexed-name": "Adam R."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Van Cutsem E, Cervantes A, Adam R, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016;27(8):1386-1422."
                    },
                    {
                        "ref-fulltext": "Modest, D.P., Ricard, I., Heinemann, V., et al. Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group. Ann Oncol 27:9 (2016), 1746\u20131753.",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib3",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84995684223",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "27",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "1746",
                                    "@last": "1753"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.P.",
                                        "@_fa": "true",
                                        "ce:surname": "Modest",
                                        "ce:indexed-name": "Modest D.P."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "I.",
                                        "@_fa": "true",
                                        "ce:surname": "Ricard",
                                        "ce:indexed-name": "Ricard I."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "V.",
                                        "@_fa": "true",
                                        "ce:surname": "Heinemann",
                                        "ce:indexed-name": "Heinemann V."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Modest DP, Ricard I, Heinemann V, et al. Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group. Ann Oncol. 2016;27(9):1746-1753."
                    },
                    {
                        "ref-fulltext": "Richman, S.D., Seymour, M.T., Chambers, P., et al. KRAS and BRAF mutations in advanced colorectal cancer are associated with poor prognosis but do not preclude benefit from oxaliplatin or irinotecan: results from the MRC FOCUS trial. J Clin Oncol 27:35 (2009), 5931\u20135937.",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "KRAS and BRAF mutations in advanced colorectal cancer are associated with poor prognosis but do not preclude benefit from oxaliplatin or irinotecan: results from the MRC FOCUS trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib4",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "73349114941",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "27",
                                    "@issue": "35"
                                },
                                "pagerange": {
                                    "@first": "5931",
                                    "@last": "5937"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.D.",
                                        "@_fa": "true",
                                        "ce:surname": "Richman",
                                        "ce:indexed-name": "Richman S.D."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.T.",
                                        "@_fa": "true",
                                        "ce:surname": "Seymour",
                                        "ce:indexed-name": "Seymour M.T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Chambers",
                                        "ce:indexed-name": "Chambers P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Richman SD, Seymour MT, Chambers P, et al. KRAS and BRAF mutations in advanced colorectal cancer are associated with poor prognosis but do not preclude benefit from oxaliplatin or irinotecan: results from the MRC FOCUS trial. J Clin Oncol. 2009;27(35):5931-5937."
                    },
                    {
                        "ref-fulltext": "Vaughn, C.P., Zobell, S.D., Furtado, L.V., Baker, C.L., Samowitz, W.S., Frequency of KRAS, BRAF, and NRAS mutations in colorectal cancer. Genes Chromosomes Cancer 50:5 (2011), 307\u2013312.",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Frequency of KRAS, BRAF, and NRAS mutations in colorectal cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib5",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "79952392909",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "50",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "307",
                                    "@last": "312"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "C.P.",
                                    "@_fa": "true",
                                    "ce:surname": "Vaughn",
                                    "ce:indexed-name": "Vaughn C.P."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.D.",
                                    "@_fa": "true",
                                    "ce:surname": "Zobell",
                                    "ce:indexed-name": "Zobell S.D."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "L.V.",
                                    "@_fa": "true",
                                    "ce:surname": "Furtado",
                                    "ce:indexed-name": "Furtado L.V."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "C.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Baker",
                                    "ce:indexed-name": "Baker C.L."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "W.S.",
                                    "@_fa": "true",
                                    "ce:surname": "Samowitz",
                                    "ce:indexed-name": "Samowitz W.S."
                                }
                            ]},
                            "ref-sourcetitle": "Genes Chromosomes Cancer"
                        },
                        "ce:source-text": "Vaughn CP, Zobell SD, Furtado LV, Baker CL, Samowitz WS. Frequency of KRAS, BRAF, and NRAS mutations in colorectal cancer. Genes Chromosomes Cancer. 2011;50(5):307-312."
                    },
                    {
                        "ref-fulltext": "Jones, R.P., Sutton, P.A., Evans, J.P., et al. Specific mutations in KRAS codon 12 are associated with worse overall survival in patients with advanced and recurrent colorectal cancer. Br J Cancer 116:7 (2017), 923\u2013929.",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Specific mutations in KRAS codon 12 are associated with worse overall survival in patients with advanced and recurrent colorectal cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib6",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85013055128",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "116",
                                    "@issue": "7"
                                },
                                "pagerange": {
                                    "@first": "923",
                                    "@last": "929"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.P.",
                                        "@_fa": "true",
                                        "ce:surname": "Jones",
                                        "ce:indexed-name": "Jones R.P."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Sutton",
                                        "ce:indexed-name": "Sutton P.A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.P.",
                                        "@_fa": "true",
                                        "ce:surname": "Evans",
                                        "ce:indexed-name": "Evans J.P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Br J Cancer"
                        },
                        "ce:source-text": "Jones RP, Sutton PA, Evans JP, et al. Specific mutations in KRAS codon 12 are associated with worse overall survival in patients with advanced and recurrent colorectal cancer. Br J Cancer. 2017;116(7):923-929."
                    },
                    {
                        "ref-fulltext": "Margonis, G.A., Kim, Y., Spolverato, G., et al. Association between specific mutations in KRAS codon 12 and colorectal liver metastasis. JAMA Surg 150:8 (2015), 722\u2013729.",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Association between specific mutations in KRAS codon 12 and colorectal liver metastasis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib7",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84939864100",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "150",
                                    "@issue": "8"
                                },
                                "pagerange": {
                                    "@first": "722",
                                    "@last": "729"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "G.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Margonis",
                                        "ce:indexed-name": "Margonis G.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Kim",
                                        "ce:indexed-name": "Kim Y."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Spolverato",
                                        "ce:indexed-name": "Spolverato G."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "JAMA Surg"
                        },
                        "ce:source-text": "Margonis GA, Kim Y, Spolverato G, et al. Association between specific mutations in KRAS codon 12 and colorectal liver metastasis. JAMA Surg. 2015;150(8):722-729."
                    },
                    {
                        "ref-fulltext": "Chen, J., Guo, F., Shi, X., et al. BRAF V600E mutation and KRAS codon 13 mutations predict poor survival in Chinese colorectal cancer patients. BMC Cancer, 14, 2014, 802.",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "BRAF V600E mutation and KRAS codon 13 mutations predict poor survival in Chinese colorectal cancer patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib8",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84920846669",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "14"},
                                "pagerange": {"@first": "802"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Chen",
                                        "ce:indexed-name": "Chen J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Guo",
                                        "ce:indexed-name": "Guo F."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "X.",
                                        "@_fa": "true",
                                        "ce:surname": "Shi",
                                        "ce:indexed-name": "Shi X."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "BMC Cancer"
                        },
                        "ce:source-text": "Chen J, Guo F, Shi X, et al. BRAF V600E mutation and KRAS codon 13 mutations predict poor survival in Chinese colorectal cancer patients. BMC Cancer. 2014;14:802."
                    },
                    {
                        "ref-fulltext": "Kwak, M.S., Cha, J.M., Yoon, J.Y., et al. Prognostic value of KRAS codon 13 gene mutation for overall survival in colorectal cancer: Direct and indirect comparison meta-analysis. Medicine (Baltimore), 96(35), 2017, e7882.",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Prognostic value of KRAS codon 13 gene mutation for overall survival in colorectal cancer: Direct and indirect comparison meta-analysis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib9",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "e7882",
                                    "@idtype": "ARTNUM"
                                },
                                {
                                    "$": "85028692130",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {
                                "@volume": "96",
                                "@issue": "35"
                            }},
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Kwak",
                                        "ce:indexed-name": "Kwak M.S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Cha",
                                        "ce:indexed-name": "Cha J.M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Yoon",
                                        "ce:indexed-name": "Yoon J.Y."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Medicine (Baltimore)"
                        },
                        "ce:source-text": "Kwak MS, Cha JM, Yoon JY, et al. Prognostic value of KRAS codon 13 gene mutation for overall survival in colorectal cancer: Direct and indirect comparison meta-analysis. Medicine (Baltimore). 2017;96(35):e7882."
                    },
                    {
                        "ref-fulltext": "Renaud, S., Guerrera, F., Seitlinger, J., et al. KRAS exon 2 codon 13 mutation is associated with a better prognosis than codon 12 mutation following lung metastasectomy in colorectal cancer. Oncotarget 8:2 (2017), 2514\u20132524.",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "KRAS exon 2 codon 13 mutation is associated with a better prognosis than codon 12 mutation following lung metastasectomy in colorectal cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib10",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85009740692",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "8",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "2514",
                                    "@last": "2524"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Renaud",
                                        "ce:indexed-name": "Renaud S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Guerrera",
                                        "ce:indexed-name": "Guerrera F."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Seitlinger",
                                        "ce:indexed-name": "Seitlinger J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Oncotarget"
                        },
                        "ce:source-text": "Renaud S, Guerrera F, Seitlinger J, et al. KRAS exon 2 codon 13 mutation is associated with a better prognosis than codon 12 mutation following lung metastasectomy in colorectal cancer. Oncotarget. 2017;8(2):2514-2524."
                    },
                    {
                        "ref-fulltext": "Pharmaceuticals and Medical Devices Agency (PMDA). 2014 18 February. Review report: Lonsurf. Available at https://www.pmda.go.jp/files/000207987.pdf. (Accessed 18 February 2021)",
                        "@id": "11",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.pmda.go.jp/files/000207987.pdf",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "2014 18 February. Review report: Lonsurf"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib11",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85131752486",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "Available at (Accessed 18 February 2021)",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "Pharmaceuticals and Medical Devices Agency (PMDA)",
                                "ce:indexed-name": "Pharmaceuticals and Medical Devices Agency (PMDA)"
                            }}
                        },
                        "ce:source-text": "Pharmaceuticals and Medical Devices Agency (PMDA). 2014 18 February. Review report: Lonsurf. Available at https://www.pmda.go.jp/files/000207987.pdf. Accessed February 18, 2021."
                    },
                    {
                        "ref-fulltext": "U.S. Food and Drug Administration (FDA). 2015 16 February. Lonsurf: Prescribing information. Available at https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207981s009lbl.pdf. (Accessed 16 February 2021)",
                        "@id": "12",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207981s009lbl.pdf",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "2015 16 February. Lonsurf: Prescribing information"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib12",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85131751051",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "Available at (Accessed 16 February 2021)",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "U.S. Food and Drug Administration (FDA)",
                                "ce:indexed-name": "U.S. Food and Drug Administration (FDA)"
                            }}
                        },
                        "ce:source-text": "U.S. Food and Drug Administration (FDA). 2015 16 February. Lonsurf: Prescribing information. Available at https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207981s009lbl.pdf. Accessed February 16, 2021."
                    },
                    {
                        "ref-fulltext": "European Medicines Agency (EMA). 2016 16 February. Lonsurf: EPAR - Product information. Available at https://www.ema.europa.eu/en/documents/product-information/lonsurf-epar-product-information_en.pdf. (Accessed 16 February 2021)",
                        "@id": "13",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.ema.europa.eu/en/documents/product-information/lonsurf-epar-product-information_en.pdf",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "2016 16 February. Lonsurf: EPAR - Product information"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib13",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85131746828",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "Available at (Accessed 16 February 2021)",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "European Medicines Agency (EMA)",
                                "ce:indexed-name": "European Medicines Agency (EMA)"
                            }}
                        },
                        "ce:source-text": "European Medicines Agency (EMA). 2016 16 February. Lonsurf: EPAR - Product information. Available at https://www.ema.europa.eu/en/documents/product-information/lonsurf-epar-product-information_en.pdf. Accessed 16 February, 2021."
                    },
                    {
                        "ref-fulltext": "Mayer, R.J., Van Cutsem, E., Falcone, A., et al. Randomized trial of TAS-102 for refractory metastatic colorectal cancer. N Engl J Med 372:20 (2015), 1909\u20131919.",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Randomized trial of TAS-102 for refractory metastatic colorectal cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib14",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84929310633",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "372",
                                    "@issue": "20"
                                },
                                "pagerange": {
                                    "@first": "1909",
                                    "@last": "1919"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Mayer",
                                        "ce:indexed-name": "Mayer R.J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Van Cutsem",
                                        "ce:indexed-name": "Van Cutsem E."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Falcone",
                                        "ce:indexed-name": "Falcone A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Mayer RJ, Van Cutsem E, Falcone A, et al. Randomized trial of TAS-102 for refractory metastatic colorectal cancer. N Engl J Med. 2015;372(20):1909-1919."
                    },
                    {
                        "ref-fulltext": "Xu, J., Kim, T.W., Shen, L., et al. Results of a randomized, double-blind, placebo-controlled, phase III trial of trifluridine/tipiracil (TAS-102) monotherapy in Asian patients with previously treated metastatic colorectal cancer: the TERRA study. J Clin Oncol 36:4 (2018), 350\u2013358.",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Results of a randomized, double-blind, placebo-controlled, phase III trial of trifluridine/tipiracil (TAS-102) monotherapy in Asian patients with previously treated metastatic colorectal cancer: the TERRA study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib15",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85041216434",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "36",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "350",
                                    "@last": "358"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Xu",
                                        "ce:indexed-name": "Xu J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.W.",
                                        "@_fa": "true",
                                        "ce:surname": "Kim",
                                        "ce:indexed-name": "Kim T.W."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Shen",
                                        "ce:indexed-name": "Shen L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Xu J, Kim TW, Shen L, et al. Results of a randomized, double-blind, placebo-controlled, phase III trial of trifluridine/tipiracil (TAS-102) monotherapy in Asian patients with previously treated metastatic colorectal cancer: the TERRA study. J Clin Oncol. 2018;36(4):350-358."
                    },
                    {
                        "ref-fulltext": "Yoshino, T., Mizunuma, N., Yamazaki, K., et al. TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trial. Lancet Oncol 13:10 (2012), 993\u20131001.",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib16",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84866925889",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "13",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "993",
                                    "@last": "1001"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Yoshino",
                                        "ce:indexed-name": "Yoshino T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Mizunuma",
                                        "ce:indexed-name": "Mizunuma N."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Yamazaki",
                                        "ce:indexed-name": "Yamazaki K."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol"
                        },
                        "ce:source-text": "Yoshino T, Mizunuma N, Yamazaki K, et al. TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trial. Lancet Oncol. 2012;13(10):993-1001."
                    },
                    {
                        "ref-fulltext": "Van Cutsem, E., Mayer, R.J., Laurent, S., et al. The subgroups of the phase III RECOURSE trial of trifluridine/tipiracil (TAS-102) versus placebo with best supportive care in patients with metastatic colorectal cancer. Eur J Cancer 90 (2018), 63\u201372.",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "The subgroups of the phase III RECOURSE trial of trifluridine/tipiracil (TAS-102) versus placebo with best supportive care in patients with metastatic colorectal cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib17",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85038877866",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "90"},
                                "pagerange": {
                                    "@first": "63",
                                    "@last": "72"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Van Cutsem",
                                        "ce:indexed-name": "Van Cutsem E."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Mayer",
                                        "ce:indexed-name": "Mayer R.J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Laurent",
                                        "ce:indexed-name": "Laurent S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Eur J Cancer"
                        },
                        "ce:source-text": "Van Cutsem E, Mayer RJ, Laurent S, et al. The subgroups of the phase III RECOURSE trial of trifluridine/tipiracil (TAS-102) versus placebo with best supportive care in patients with metastatic colorectal cancer. Eur J Cancer. 2018;90:63-72."
                    },
                    {
                        "ref-fulltext": "Yoshino, T., Shinozaki, E., Yamazaki, K., et al. PD-014 Final survival results and onset of neutropenia as an indicator of therapeutic effect in phase 2 of TAS-102 vs placebo with metastatic colorectal cancer (J003-10040030). Ann Oncol, 27, 2016, ii107.",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "PD-014 Final survival results and onset of neutropenia as an indicator of therapeutic effect in phase 2 of TAS-102 vs placebo with metastatic colorectal cancer (J003-10040030)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib18",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85029012132",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "27"},
                                "pagerange": {"@first": "ii107"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Yoshino",
                                        "ce:indexed-name": "Yoshino T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Shinozaki",
                                        "ce:indexed-name": "Shinozaki E."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Yamazaki",
                                        "ce:indexed-name": "Yamazaki K."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Yoshino T, Shinozaki E, Yamazaki K, et al. PD-014 Final survival results and onset of neutropenia as an indicator of therapeutic effect in phase 2 of TAS-102 vs placebo with metastatic colorectal cancer (J003-10040030). Ann Oncol. 2016;27:ii107."
                    },
                    {
                        "ref-fulltext": "Katsahian, S., Latouche, A., Mary, J.Y., Chevret, S., Porcher, R., Practical methodology of meta-analysis of individual patient data using a survival outcome. Contemp Clin Trials 29:2 (2008), 220\u2013230.",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Practical methodology of meta-analysis of individual patient data using a survival outcome"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib20",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "39049119762",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "29",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "220",
                                    "@last": "230"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Katsahian",
                                    "ce:indexed-name": "Katsahian S."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Latouche",
                                    "ce:indexed-name": "Latouche A."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J.Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Mary",
                                    "ce:indexed-name": "Mary J.Y."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Chevret",
                                    "ce:indexed-name": "Chevret S."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Porcher",
                                    "ce:indexed-name": "Porcher R."
                                }
                            ]},
                            "ref-sourcetitle": "Contemp Clin Trials"
                        },
                        "ce:source-text": "Katsahian S, Latouche A, Mary JY, Chevret S, Porcher R. Practical methodology of meta-analysis of individual patient data using a survival outcome. Contemp Clin Trials. 2008;29(2):220-230."
                    },
                    {
                        "ref-fulltext": "Package \u2018meta\u2019, 2021 1 April 2021. General Package for Meta-Analysis. Version 4.18-0. Available at https://cran.r-project.org/web/packages/meta/meta.pdf. (Accessed 1 April 2021)",
                        "@id": "20",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "https://cran.r-project.org/web/packages/meta/meta.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib19",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85131730670",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "Available at (Accessed 1 April 2021)",
                            "ref-authors": {"collaboration": [
                                {
                                    "@seq": "1",
                                    "ce:text": "Package \u2018meta\u2019",
                                    "ce:indexed-name": "Package 'meta'"
                                },
                                {
                                    "@seq": "2",
                                    "ce:text": "2021 1 April 2021. General Package for Meta-Analysis. Version 4.18-0",
                                    "ce:indexed-name": "2021 1 April 2021. General Package for Meta-Analysis. Version 4.18-0"
                                }
                            ]}
                        },
                        "ce:source-text": "Package \u2018meta\u2019. 2021 1 April 2021. General Package for Meta-Analysis. Version 4.18-0. Available at https://cran.r-project.org/web/packages/meta/meta.pdf. Accessed April 1, 2021."
                    },
                    {
                        "ref-fulltext": "Previous Releases of R for Windows. 1 April 2021. R 3.6.1 (July 2019). Available at https://cran.r-project.org/bin/windows/base/old/. (Accessed 1 April 2021)",
                        "@id": "21",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "https://cran.r-project.org/bin/windows/base/old/",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Previous Releases of R for Windows. 1 April 2021. R 3.6.1 (July 2019)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib21",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85131756740",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "Available at (Accessed 1 April 2021)"
                        },
                        "ce:source-text": "Previous Releases of R for Windows. 1 April 2021. R 3.6.1 (July 2019). Available at https://cran.r-project.org/bin/windows/base/old/. Accessed April 1, 2021."
                    },
                    {
                        "ref-fulltext": "Garcia-Carbonero, N., Martinez-Useros, J., Li, W., et al. KRAS and BRAF mutations as prognostic and predictive biomarkers for standard chemotherapy response in metastatic colorectal cancer: a single institutional study. Cells, 9(1), 2020, 219.",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "KRAS and BRAF mutations as prognostic and predictive biomarkers for standard chemotherapy response in metastatic colorectal cancer: a single institutional study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib22",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85087821615",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "9",
                                    "@issue": "1"
                                },
                                "pagerange": {"@first": "219"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Garcia-Carbonero",
                                        "ce:indexed-name": "Garcia-Carbonero N."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Martinez-Useros",
                                        "ce:indexed-name": "Martinez-Useros J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "W.",
                                        "@_fa": "true",
                                        "ce:surname": "Li",
                                        "ce:indexed-name": "Li W."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cells"
                        },
                        "ce:source-text": "Garcia-Carbonero N, Martinez-Useros J, Li W, et al. KRAS and BRAF mutations as prognostic and predictive biomarkers for standard chemotherapy response in metastatic colorectal cancer: a single institutional study. Cells. 2020;9(1):219."
                    },
                    {
                        "ref-fulltext": "Camaj, P., Primo, S., Wang, Y., et al. KRAS exon 2 mutations influence activity of regorafenib in an SW48-based disease model of colorectal cancer. Future Oncol 11:13 (2015), 1919\u20131929.",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "KRAS exon 2 mutations influence activity of regorafenib in an SW48-based disease model of colorectal cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib23",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84936931939",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "11",
                                    "@issue": "13"
                                },
                                "pagerange": {
                                    "@first": "1919",
                                    "@last": "1929"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Camaj",
                                        "ce:indexed-name": "Camaj P."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Primo",
                                        "ce:indexed-name": "Primo S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Wang",
                                        "ce:indexed-name": "Wang Y."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Future Oncol"
                        },
                        "ce:source-text": "Camaj P, Primo S, Wang Y, et al. KRAS exon 2 mutations influence activity of regorafenib in an SW48-based disease model of colorectal cancer. Future Oncol. 2015;11(13):1919-1929."
                    },
                    {
                        "ref-fulltext": "Bai, B., Shan, L., Xie, B., et al. Mutations in KRAS codon 12 predict poor survival in Chinese patients with metastatic colorectal cancer. Oncol Lett 15:3 (2018), 3161\u20133166.",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Mutations in KRAS codon 12 predict poor survival in Chinese patients with metastatic colorectal cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib24",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85040809327",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "15",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "3161",
                                    "@last": "3166"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Bai",
                                        "ce:indexed-name": "Bai B."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Shan",
                                        "ce:indexed-name": "Shan L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Xie",
                                        "ce:indexed-name": "Xie B."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Oncol Lett"
                        },
                        "ce:source-text": "Bai B, Shan L, Xie B, et al. Mutations in KRAS codon 12 predict poor survival in Chinese patients with metastatic colorectal cancer. Oncol Lett. 2018;15(3):3161-3166."
                    },
                    {
                        "ref-fulltext": "Chen, D., Wu, Y.S., Lin, H., Wang, Y., Li, L., Zhang, T., Efficacy and safety of TAS-102 in refractory metastatic colorectal cancer: a meta-analysis. Cancer Manag Res 10 (2018), 2915\u20132924.",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Efficacy and safety of TAS-102 in refractory metastatic colorectal cancer: a meta-analysis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib25",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85057586998",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "10"},
                                "pagerange": {
                                    "@first": "2915",
                                    "@last": "2924"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Chen",
                                    "ce:indexed-name": "Chen D."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "Y.S.",
                                    "@_fa": "true",
                                    "ce:surname": "Wu",
                                    "ce:indexed-name": "Wu Y.S."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Lin",
                                    "ce:indexed-name": "Lin H."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Wang",
                                    "ce:indexed-name": "Wang Y."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Li",
                                    "ce:indexed-name": "Li L."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Zhang",
                                    "ce:indexed-name": "Zhang T."
                                }
                            ]},
                            "ref-sourcetitle": "Cancer Manag Res"
                        },
                        "ce:source-text": "Chen D, Wu YS, Lin H, Wang Y, Li L, Zhang T. Efficacy and safety of TAS-102 in refractory metastatic colorectal cancer: a meta-analysis. Cancer Manag Res. 2018;10:2915-2924."
                    },
                    {
                        "ref-fulltext": "Kwakman, J.J.M., Vink, G., Vestjens, J.H., et al. Feasibility and effectiveness of trifluridine/tipiracil in metastatic colorectal cancer: real-life data from The Netherlands. Int J Clin Oncol 23:3 (2018), 482\u2013489.",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Feasibility and effectiveness of trifluridine/tipiracil in metastatic colorectal cancer: real-life data from The Netherlands"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib26",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85036543483",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "23",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "482",
                                    "@last": "489"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.J.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Kwakman",
                                        "ce:indexed-name": "Kwakman J.J.M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Vink",
                                        "ce:indexed-name": "Vink G."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Vestjens",
                                        "ce:indexed-name": "Vestjens J.H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Int J Clin Oncol"
                        },
                        "ce:source-text": "Kwakman JJM, Vink G, Vestjens JH, et al. Feasibility and effectiveness of trifluridine/tipiracil in metastatic colorectal cancer: real-life data from The Netherlands. Int J Clin Oncol. 2018;23(3):482-489."
                    },
                    {
                        "ref-fulltext": "Tabernero, J., Argiles, G., Sobrero, A.F., et al. Effect of trifluridine/tipiracil in patients treated in RECOURSE by prognostic factors at baseline: an exploratory analysis. ESMO Open, 5(4), 2020, e000752.",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Effect of trifluridine/tipiracil in patients treated in RECOURSE by prognostic factors at baseline: an exploratory analysis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib27",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "e000752",
                                    "@idtype": "ARTNUM"
                                },
                                {
                                    "$": "85089769153",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {
                                "@volume": "5",
                                "@issue": "4"
                            }},
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Tabernero",
                                        "ce:indexed-name": "Tabernero J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Argiles",
                                        "ce:indexed-name": "Argiles G."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.F.",
                                        "@_fa": "true",
                                        "ce:surname": "Sobrero",
                                        "ce:indexed-name": "Sobrero A.F."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "ESMO Open"
                        },
                        "ce:source-text": "Tabernero J, Argiles G, Sobrero AF, et al. Effect of trifluridine/tipiracil in patients treated in RECOURSE by prognostic factors at baseline: an exploratory analysis. ESMO Open. 2020;5(4):e000752."
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Shanghai",
            "@id": "60121918",
            "affilname": "Shanghai Dongfang Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60121918",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Seoul",
            "@id": "60068691",
            "affilname": "Asan Medical Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60068691",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Leuven",
            "@id": "60031069",
            "affilname": "KU Leuven\u2013 University Hospital Leuven",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031069",
            "affiliation-country": "Belgium"
        },
        {
            "affiliation-city": "Boston",
            "@id": "60014334",
            "affilname": "Dana-Farber Cancer Institute",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60014334",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Kashiwa",
            "@id": "60010925",
            "affilname": "National Cancer Center Hospital East",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010925",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Beijing",
            "@id": "60008510",
            "affilname": "Beijing Cancer Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60008510",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Courbevoie",
            "@id": "60004412",
            "affilname": "IRIS Institut de Recherches Internationales Servier",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60004412",
            "affiliation-country": "France"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85131739522",
        "dc:description": "Background: KRAS gene mutations can predict prognosis and treatment response in patients with metastatic colorectal cancer (mCRC). Methods: We undertook a meta-analysis of three randomized, placebo-controlled trials (RECOURSE, TERRA and J003) to investigate the impact of KRAS mutations in codons 12 or 13 on overall survival (OS) and progression-free survival in patients receiving trifluridine/tipiracil (FTD/TPI) for refractory mCRC. Results: A total of 1375 patients were included, of whom 478 had a KRAS codon 12 mutation and 130 had a KRAS codon 13 mutation. In univariate analyses, the absence of a KRAS codon 12 mutation was found to significantly increase the OS benefit of FTD/TPI relative to placebo compared with the presence of the mutation {hazard ratio (HR), 0.62 [95% confidence interval (CI): 0.53-0.72] versus 0.86 (0.70-1.05), respectively; interaction P = 0.0206}. Multivariate analyses showed that taking confounding factors into account reduced the difference in treatment effect between the presence and the absence of KRAS codon 12 mutations, confirming that treatment benefit was maintained in patients with [HR, 0.73 (95% CI: 0.59-0.89)] and without [HR, 0.63 (95% CI: 0.54-0.74)] codon 12 mutations (interaction P = 0.2939). KRAS mutations in codon 13 did not reduce the OS benefit of FTD/TPI relative to placebo, and, furthermore, KRAS mutations at either codon 12 or codon 13 did not affect the progression-free survival benefit. Conclusions: Treatment with FTD/TPI produced a survival benefit, relative to placebo, regardless of KRAS codon 12 or 13 mutation status in patients with previously treated mCRC.",
        "pubmed-id": "35688062",
        "prism:coverDate": "2022-06-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85131739522",
        "dc:creator": {"author": [{
            "preferred-name": {
                "ce:given-name": "T.",
                "ce:initials": "T.",
                "ce:surname": "Yoshino",
                "ce:indexed-name": "Yoshino T."
            },
            "@seq": "1",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60010925",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010925"
            },
            "ce:surname": "Yoshino",
            "@auid": "57205400013",
            "author-url": "https://api.elsevier.com/content/author/author_id/57205400013",
            "ce:indexed-name": "Yoshino T."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85131739522"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85131739522&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85131739522&origin=inward"
            }
        ],
        "source-id": "21100873339",
        "pii": "S2059702922001314",
        "citedby-count": "5",
        "prism:volume": "7",
        "subtype": "ar",
        "dc:title": "Effect of KRAS codon 12 or 13 mutations on survival with trifluridine/tipiracil in pretreated metastatic colorectal cancer: a meta-analysis",
        "openaccess": "1",
        "prism:issn": "20597029",
        "publishercopyright": "Â© 2022 The Author(s)",
        "article-number": "100511",
        "prism:issueIdentifier": "3",
        "subtypeDescription": "Article",
        "prism:publicationName": "ESMO Open",
        "openaccessFlag": "true",
        "prism:doi": "10.1016/j.esmoop.2022.100511",
        "dc:identifier": "SCOPUS_ID:85131739522",
        "dc:publisher": "Elsevier B.V."
    },
    "idxterms": {"mainterm": [
        {
            "$": "Codon",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Colonic Neoplasms",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Colorectal Neoplasms",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Frontotemporal Dementia",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Mutation",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Proto-Oncogene Proteins p21(ras)",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Pyrrolidines",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Thymine",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Trifluridine",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Uracil",
            "@weight": "b",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "KRAS"
        },
        {
            "@_fa": "true",
            "$": "meta-analysis"
        },
        {
            "@_fa": "true",
            "$": "metastatic colorectal cancer"
        },
        {
            "@_fa": "true",
            "$": "survival"
        },
        {
            "@_fa": "true",
            "$": "trifluridine/tipiracil"
        }
    ]},
    "subject-areas": {"subject-area": [
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cancer Research",
            "@code": "1306",
            "@abbrev": "BIOC"
        }
    ]},
    "authors": {"author": [
        {
            "preferred-name": {
                "ce:given-name": "T.",
                "ce:initials": "T.",
                "ce:surname": "Yoshino",
                "ce:indexed-name": "Yoshino T."
            },
            "@seq": "1",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60010925",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010925"
            },
            "ce:surname": "Yoshino",
            "@auid": "57205400013",
            "author-url": "https://api.elsevier.com/content/author/author_id/57205400013",
            "ce:indexed-name": "Yoshino T."
        },
        {
            "preferred-name": {
                "ce:given-name": "E.",
                "ce:initials": "E.",
                "ce:surname": "Van Cutsem",
                "ce:indexed-name": "Van Cutsem E."
            },
            "@seq": "2",
            "ce:initials": "E.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60031069",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031069"
            },
            "ce:surname": "Van Cutsem",
            "@auid": "7005959932",
            "author-url": "https://api.elsevier.com/content/author/author_id/7005959932",
            "ce:indexed-name": "Van Cutsem E."
        },
        {
            "preferred-name": {
                "ce:given-name": "J.",
                "ce:initials": "J.",
                "ce:surname": "Li",
                "ce:indexed-name": "Li J."
            },
            "@seq": "3",
            "ce:initials": "J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60121918",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60121918"
            },
            "ce:surname": "Li",
            "@auid": "57190345301",
            "author-url": "https://api.elsevier.com/content/author/author_id/57190345301",
            "ce:indexed-name": "Li J."
        },
        {
            "preferred-name": {
                "ce:given-name": "L.",
                "ce:initials": "L.",
                "ce:surname": "Shen",
                "ce:indexed-name": "Shen L."
            },
            "@seq": "4",
            "ce:initials": "L.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60008510",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60008510"
            },
            "ce:surname": "Shen",
            "@auid": "57250380300",
            "author-url": "https://api.elsevier.com/content/author/author_id/57250380300",
            "ce:indexed-name": "Shen L."
        },
        {
            "preferred-name": {
                "ce:given-name": "T. W.",
                "ce:initials": "T.W.",
                "ce:surname": "Kim",
                "ce:indexed-name": "Kim T.W."
            },
            "@seq": "5",
            "ce:initials": "T.W.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60068691",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60068691"
            },
            "ce:surname": "Kim",
            "@auid": "56504151300",
            "author-url": "https://api.elsevier.com/content/author/author_id/56504151300",
            "ce:indexed-name": "Kim T.W."
        },
        {
            "preferred-name": {
                "ce:given-name": "V.",
                "ce:initials": "V.",
                "ce:surname": "Sriuranpong",
                "ce:indexed-name": "Sriuranpong V."
            },
            "@seq": "6",
            "ce:initials": "V.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002620",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
            },
            "ce:surname": "Sriuranpong",
            "@auid": "6603599644",
            "author-url": "https://api.elsevier.com/content/author/author_id/6603599644",
            "ce:indexed-name": "Sriuranpong V."
        },
        {
            "preferred-name": {
                "ce:given-name": "L.",
                "ce:initials": "L.",
                "ce:surname": "Xuereb",
                "ce:indexed-name": "Xuereb L."
            },
            "@seq": "7",
            "ce:initials": "L.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60004412",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60004412"
            },
            "ce:surname": "Xuereb",
            "@auid": "36626782800",
            "author-url": "https://api.elsevier.com/content/author/author_id/36626782800",
            "ce:indexed-name": "Xuereb L."
        },
        {
            "preferred-name": {
                "ce:given-name": "P.",
                "ce:initials": "P.",
                "ce:surname": "Aubel",
                "ce:indexed-name": "Aubel P."
            },
            "@seq": "8",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60004412",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60004412"
            },
            "ce:surname": "Aubel",
            "@auid": "57218401600",
            "author-url": "https://api.elsevier.com/content/author/author_id/57218401600",
            "ce:indexed-name": "Aubel P."
        },
        {
            "preferred-name": {
                "ce:given-name": "R.",
                "ce:initials": "R.",
                "ce:surname": "Fougeray",
                "ce:indexed-name": "Fougeray R."
            },
            "@seq": "9",
            "ce:initials": "R.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60004412",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60004412"
            },
            "ce:surname": "Fougeray",
            "@auid": "57579080500",
            "author-url": "https://api.elsevier.com/content/author/author_id/57579080500",
            "ce:indexed-name": "Fougeray R."
        },
        {
            "preferred-name": {
                "ce:given-name": "V.",
                "ce:initials": "V.",
                "ce:surname": "Cattan",
                "ce:indexed-name": "Cattan V."
            },
            "@seq": "10",
            "ce:initials": "V.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60004412",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60004412"
            },
            "ce:surname": "Cattan",
            "@auid": "57212115567",
            "author-url": "https://api.elsevier.com/content/author/author_id/57212115567",
            "ce:indexed-name": "Cattan V."
        },
        {
            "preferred-name": {
                "ce:given-name": "N.",
                "ce:initials": "N.",
                "ce:surname": "Amellal",
                "ce:indexed-name": "Amellal N."
            },
            "@seq": "11",
            "ce:initials": "N.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60004412",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60004412"
            },
            "ce:surname": "Amellal",
            "@auid": "57214141930",
            "author-url": "https://api.elsevier.com/content/author/author_id/57214141930",
            "ce:indexed-name": "Amellal N."
        },
        {
            "preferred-name": {
                "ce:given-name": "A.",
                "ce:initials": "A.",
                "ce:surname": "Ohtsu",
                "ce:indexed-name": "Ohtsu A."
            },
            "@seq": "12",
            "ce:initials": "A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60010925",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010925"
            },
            "ce:surname": "Ohtsu",
            "@auid": "7005282688",
            "author-url": "https://api.elsevier.com/content/author/author_id/7005282688",
            "ce:indexed-name": "Ohtsu A."
        },
        {
            "preferred-name": {
                "ce:given-name": "R. J.",
                "ce:initials": "R.J.",
                "ce:surname": "Mayer",
                "ce:indexed-name": "Mayer R.J."
            },
            "@seq": "13",
            "ce:initials": "R.J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60014334",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60014334"
            },
            "ce:surname": "Mayer",
            "@auid": "57203233795",
            "author-url": "https://api.elsevier.com/content/author/author_id/57203233795",
            "ce:indexed-name": "Mayer R.J."
        }
    ]}
}}